Nature Communications (Jan 2020)
Rational design of universal immunotherapy for TfR1-tropic arenaviruses
Abstract
New World arenaviruses utilize the cellular transferrin receptor 1 (TfR1) to enter host cells. Here, the authors develop a TfR1-mimetic immunoadhesin, Arenacept, that targets viral spike complexes and exerts effective pan-reactive neutralization against pathogenic mammarenaviruses.